Right parietal inhibition with repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression

St. Lucas Andreas Hospital (Netherlands)0 个研究点目标入组 40 人开始时间: 2005年12月20日最近更新: 2019年2月11日

适应症

试验速览

暂无简介。

•1. In- and out-patients, aged between 16 and 65 years
•2. Meet Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria for major depressive episode
•3. Have a score of 25 or higher on the 10-item Montgomery Asberg Depression Rating Scale (MADRS)

•1. A history of epilepsy or any other medical disorder that should preclude the administration of rTMS. Only selective serotonin reuptake inhibitors (SSRIs), mirtazapine and promethazine as psychotropic medication was accepted if the dosage of antidepressive medication had not been changed for 6 weeks, and if the dosage of promethazine had not been changed for 2 weeks prior to inclusion.
•2. Antidepressive medication had to remain stable during the 14 weeks of the study
•3. Schizophrenic disorder
•4. A piece if metal in the brain
•5. Pacemaker
•6. Left-handed patients

发起方

St. Lucas Andreas Hospital (Netherlands)